Form 4: COO Robert Ainscow Adjusts ASPI Holdings
Insider Transaction Report
ASP Isotopes Inc.'s Chief Operating Officer, Robert Ainscow, reported significant changes in his beneficial ownership, including option exercises and stock sales for tax obligations.
Summary
- Robert Ainscow, Chief Operating Officer of ASP Isotopes Inc. (ASPI), reported multiple transactions in the company's common stock and derivative securities.
- On September 8, 2025, Ainscow sold 8,438 shares of common stock at a weighted average price of $8.5263 per share, ranging from $8.31 to $8.79. This sale was executed under a Rule 10b5-1 trading plan adopted on June 9, 2025, to cover tax withholding obligations related to restricted stock awards.
- On September 9, 2025, Ainscow exercised employee stock options to acquire a total of 297,000 shares of common stock.
- Specifically, 150,000 shares were acquired at an exercise price of $0.25 per share, 12,000 shares at $2.00 per share, and 135,000 shares at $2.00 per share.
- In connection with these option exercises, the company withheld a total of 38,861 shares (4,396 shares, 2,813 shares, and 31,652 shares) at a price of $8.53 per share to satisfy the exercise price through net share settlement.
- Following these transactions, Ainscow's direct beneficial ownership of common stock increased to 1,669,693 shares.
- All derivative securities (employee stock options) involved in these transactions are now fully exercised and reported as 0 beneficially owned.
Sentiment
Score: 7
Explanation: The filing details routine insider transactions, including the exercise of stock options and subsequent sales to cover tax obligations, which is a common practice. The net increase in the COO's direct beneficial ownership is a slightly positive signal.
Positives
- The Chief Operating Officer exercised a substantial number of employee stock options (297,000 shares), indicating a positive outlook or belief in the company's value at the time of exercise.
- Robert Ainscow's direct beneficial ownership of ASP Isotopes Inc. common stock increased by 249,701 shares as a result of these transactions, demonstrating an increased stake in the company.
Negatives
- A sale of 8,438 shares of common stock occurred to cover tax withholding obligations on restricted stock awards, which, while routine, represents a reduction in direct ownership not related to option exercise.
- A total of 38,861 shares were withheld by the company to cover the exercise price of options, reducing the net number of shares received by the COO from the option exercises.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction; it is a report of past insider transactions.
Management Comments
- The sale of 8,438 shares on September 8, 2025, was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025, specifically to cover tax withholding obligations in connection with the vesting of restricted stock awards.
- Shares withheld by the company in connection with net share settlement were to satisfy the exercise price associated with the reporting person's exercise of employee stock options; no shares were sold by the reporting person to satisfy the exercise price or any tax liability in these specific instances.
Industry Context
This Form 4 filing details routine insider transactions, specifically the exercise of stock options and sales to cover tax liabilities. Such activities are common for executives in publicly traded companies and do not inherently reflect broader industry trends or competitive positioning.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Adoption of Trading Plan | The reporting person adopted a Rule 10b5-1 trading plan on June 9, 2025, for the sale of equity securities. This plan provides an affirmative defense against insider trading allegations for pre-scheduled trades. | 06/09/2025 | Enhances transparency and compliance with insider trading regulations for future sales by the reporting person. |
Related Party Transactions
- The transactions involve the Chief Operating Officer of ASP Isotopes Inc. trading in the company's securities, which are inherently related-party dealings.
Stakeholder Impact
- Shareholders: The increase in the COO's direct beneficial ownership could be viewed as a positive signal of management's alignment with shareholder interests, although the transactions are primarily compensation-related.
- Employees: The exercise of stock options is a common form of executive compensation, impacting the company's equity compensation structure.
Key Dates
| Date | Description |
|---|---|
| 10/04/2021 | Grant date for employee stock options (150,000 shares) that vested in thirty-six equal installments. |
| 04/04/2022 | Grant date for employee stock options (12,000 shares) that vested in a single installment 12 months after grant. |
| 06/10/2022 | Grant date for employee stock options (135,000 shares) that vested in thirty-six equal installments. |
| 04/04/2023 | Date employee stock options (12,000 shares) became exercisable. |
| 10/04/2024 | Date employee stock options (150,000 shares) became exercisable. |
| 06/09/2025 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 06/10/2025 | Date employee stock options (135,000 shares) became exercisable. |
| 09/08/2025 | Transaction date for the sale of 8,438 shares of common stock. |
| 09/09/2025 | Transaction date for the exercise of employee stock options and related share dispositions. |
| 09/10/2025 | Signature date of the reporting person's attorney-in-fact. |
| 10/04/2031 | Expiration date for employee stock options (150,000 shares). |
| 04/04/2032 | Expiration date for employee stock options (12,000 shares). |
| 06/10/2032 | Expiration date for employee stock options (135,000 shares). |
Recommendation
holdThe filing details routine insider transactions, including the exercise of stock options and subsequent sales to cover tax obligations. While the net effect is an increase in the COO's direct beneficial ownership, these are standard compensation-related activities and do not provide new fundamental insights to warrant a change from a 'hold' position.
Keywords
ASP Isotopes, ASPI, Robert Ainscow, Form 4, Insider Trading, Stock Options, Beneficial Ownership, Chief Operating Officer, Equity, SEC Filing, 10b5-1 Plan, Restricted Stock Awards
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.